Simple jQuery Dropdowns

Browsing by Author Ali Taher

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)
1-Jan-2011Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overloadDudley J. Pennell; John B. Porter; Maria Domenica Cappellini; Lee Lee Chan; Amal El-Beshlawy; Yesim Aydinok; Hishamshah Ibrahim; Chi Kong Li; Vip Viprakasit; Mohsen Saleh Elalfy; Antonis Kattamis; Gillian Smith; Dany Habr; Gabor Domokos; Bernard Roubert; Ali Taher; Royal Brompton Hospital; UCL; Universita degli Studi di Milano; University of Malaya Medical Centre; Cairo University; Ege University Medical School; Kuala Lumpur Hospital; Prince of Wales Hospital Hong Kong; Mahidol University; Ain Shams University; University of Athens; Novartis Pharmaceuticals; Novartis International AG; American University of Beirut
1-Jun-2012Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia majorDudley J. Pennell; John B. Porter; Maria Domenica Cappellini; Lee Lee Chan; Amal El-Beshlawy; Yesim Aydinok; Hishamshah Ibrahim; Chi Kong Li; Vip Viprakasit; Mohsen S. Elalfy; Antonis Kattamis; Gillian Smith; Dany Habr; Gabor Domokos; Bernard Roubert; Ali Taher; Royal Brompton Hospital; UCL; Universita degli Studi di Milano; University of Malaya Medical Centre; Cairo University; Ege Universitesi; Kuala Lumpur Hospital; Prince of Wales Hospital Hong Kong; Mahidol University; Ain Shams University; University of Athens; Novartis Pharmaceuticals; Novartis International AG; American University of Beirut
1-Feb-2019Development of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO <sup>©</sup> )Ali Taher; Vip Viprakasit; Maria Domenica Cappellini; Pranee Sutcharitchan; Richard Ward; Dalia Mahmoud; Abderrahmane Laadem; Anzalee Khan; Chad Gwaltney; Gale Harding; Kenneth Attie; Xiaosha Zhang; Jun Zou; Joseph Pariseau; X. Henry Hu; Antonis Kattamis; Evidera, USA; American University of Beirut Medical Center; Università degli Studi di Milano; Chulalongkorn University; Aghia Sophia Children's Hospital; Celgene Corporation; University of Toronto; Faculty of Medicine, Siriraj Hospital, Mahidol University; Nathan S. Kline Institute for Psychiatric Research; NeuroCog Trials; ERT; Acceleron Pharma
1-Oct-2019Quality of life in patients with β-thalassemia: A prospective study of transfusion-dependent and non-transfusion-dependent patients in Greece, Italy, Lebanon, and ThailandMaria Domenica Cappellini; Antonis Kattamis; Vip Viprakasit; Pranee Sutcharitchan; Joseph Pariseau; Abderrahmane Laadem; Valerie Jessent-Ciaravino; Ali Taher; American University of Beirut Medical Center; Università degli Studi di Milano; King Chulalongkorn Memorial Hospital, Faculty of Medicine Chulalongkorn University; Aghia Sophia Children's Hospital; Celgene Corporation; Faculty of Medicine, Siriraj Hospital, Mahidol University
1-May-2013A randomized phase I/II trial of HQK-1001, an oral fetal globin gene inducer, in β-thalassaemia intermedia and HbE/β-thalassaemiaSuthat Fucharoen; Adlette Inati; Noppadol Siritanaratku; Swee L. Thein; William C. Wargin; Suzanne Koussa; Ali Taher; Nattawara Chaneim; Michael Boosalis; Ronald Berenson; Susan P. Perrine; Mahidol University; Rafik El Hariri University Hospital; King's College Hospital NHS Foundation Trust; PK-PM Associates, LLC; Boston University School of Medicine; HemaQuest Pharmaceuticals
1-Apr-2010Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemiasMaria Domenica Cappellini; John Porter; Amal El-Beshlawy; Chi Kong Li; John F. Seymour; Mohsen Elalfy; Norbert Gattermann; Stéphane Giraudier; Jong Wook Lee; Lee Lee Chan; Kai Hsin Lin; Christian Rose; Ali Taher; Swee Lay Thein; Vip Viprakasit; Dany Habr; Gabor Domokos; Bernard Roubert; Antonis Kattamis; Universita degli Studi di Milano; UCL; Cairo University; Prince of Wales Hospital Hong Kong; Peter Maccallum Cancer Centre; Ain Shams University; Heinrich Heine Universitat; Hopital Henri Mondor; The Catholic University of Korea; University of Malaya Medical Centre; National Taiwan University Hospital; Hopital Saint-Vincent-de-Paul; American University of Beirut; King's College London; Mahidol University; Novartis Pharmaceuticals Corporation; Novartis International AG; University of Athens
1-Feb-2019Validation of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO <sup>©</sup> )Ali Taher; Maria Domenica Cappellini; Vip Viprakasit; Pranee Sutcharitchan; Dalia Mahmoud; Abderrahmane Laadem; Anzalee Khan; Chad Gwaltney; Gale Harding; Kenneth Attie; Xiaosha Zhang; Jun Zou; Joseph Pariseau; X. Henry Hu; Antonis Kattamis; Evidera, USA; American University of Beirut Medical Center; Università degli Studi di Milano; Chulalongkorn University; Aghia Sophia Children's Hospital; Celgene Corporation; Faculty of Medicine, Siriraj Hospital, Mahidol University; Nathan S. Kline Institute for Psychiatric Research; NeuroCog Trials; ERT; Acceleron Pharma
1-May-2007Validation of a reverse-hybridization StripAssay for the simultaneous analysis of common α-thalassemia point mutations and deletionsHelene Puehringer; Hossein Najmabadi; Hai Yang Law; Walter Krugluger; Vip Viprakasit; Serge Pissard; Erol Baysal; Ali Taher; Chantal Farra; Amein Al-Ali; Suad Al-Ateeq; Christian Oberkanins; ViennaLab Diagnostics GmbH; University of Social Welfare and Rehabilitation Sciences; KK Women's And Children's Hospital; Rudolfstifung Hospital; Mahidol University; Hopital Henri Mondor; Genetics Department; American University of Beirut Medical Center; Chronic Care Center, Hazmieh; Imam Abdulrahman Bin Faisal university